Sino Biological Inc
SZSE:301047
Sino Biological Inc
SZSE:301047
Price:
74.15
CNY
-1.46%
Market Cap:
¥9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sino Biological Inc
SZSE:301047
|
CN |
|
New Wave Group AB
STO:NEWA B
|
SE |
|
Janus Henderson Group PLC
NYSE:JHG
|
UK |
|
W
|
WidePoint Corp
AMEX:WYY
|
US |
|
Boostheat SAS
PAR:ALBOO
|
FR |
|
L
|
Lakala Payment Co Ltd
SZSE:300773
|
CN |
|
Hatsun Agro Product Ltd
NSE:HATSUN
|
IN |
|
Kidsland International Holdings Ltd
HKEX:2122
|
CN |
|
Zhejiang Wazam New Materials Co Ltd
SSE:603186
|
CN |
|
Bayer Cropscience Ltd
NSE:BAYERCROP
|
IN |
|
CSG Holding Co Ltd
SZSE:000012
|
CN |
|
N
|
Nuenergy Holdings Bhd
KLSE:NHB
|
MY |
|
M
|
Macquarie Mexico Real Estate Management SA de CV
BMV:FIBRAMQ12
|
MX |
Income Statement
Earnings Waterfall
Sino Biological Inc
Sino Biological Inc
Income Statement
Sino Biological Inc
Sino Biological Inc
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
0
|
0
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
0
|
0
|
0
|
|
| Revenue |
1 596
N/A
|
1 942
+22%
|
1 736
-11%
|
1 341
-23%
|
965
-28%
|
685
-29%
|
630
-8%
|
583
-8%
|
575
-1%
|
556
-3%
|
568
+2%
|
620
+9%
|
646
+4%
|
642
-1%
|
660
+3%
|
635
-4%
|
614
-3%
|
617
+0%
|
632
+3%
|
660
+4%
|
700
+6%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(56)
|
(72)
|
(79)
|
(78)
|
(69)
|
(68)
|
(73)
|
(84)
|
(95)
|
(99)
|
(115)
|
(119)
|
(126)
|
(133)
|
(148)
|
(156)
|
(171)
|
(181)
|
(181)
|
(193)
|
(190)
|
|
| Gross Profit |
1 541
N/A
|
1 870
+21%
|
1 657
-11%
|
1 263
-24%
|
896
-29%
|
617
-31%
|
557
-10%
|
498
-10%
|
480
-4%
|
457
-5%
|
452
-1%
|
501
+11%
|
521
+4%
|
509
-2%
|
512
+1%
|
479
-6%
|
443
-8%
|
436
-1%
|
452
+4%
|
468
+3%
|
509
+9%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(200)
|
(208)
|
(194)
|
(190)
|
(133)
|
(146)
|
(165)
|
(177)
|
(262)
|
(289)
|
(315)
|
(346)
|
(378)
|
(393)
|
(399)
|
(408)
|
(404)
|
(408)
|
(407)
|
(402)
|
(416)
|
|
| Selling, General & Administrative |
(169)
|
(169)
|
(148)
|
(144)
|
(148)
|
(155)
|
(173)
|
(193)
|
(196)
|
(223)
|
(248)
|
(261)
|
(262)
|
(304)
|
(306)
|
(318)
|
(275)
|
(316)
|
(318)
|
(310)
|
(286)
|
|
| Research & Development |
(25)
|
(28)
|
(32)
|
(39)
|
(36)
|
(42)
|
(45)
|
(47)
|
(53)
|
(73)
|
(75)
|
(82)
|
(74)
|
(88)
|
(91)
|
(93)
|
(78)
|
(91)
|
(92)
|
(91)
|
(74)
|
|
| Depreciation & Amortization |
(6)
|
(4)
|
(8)
|
0
|
(16)
|
0
|
0
|
0
|
(27)
|
0
|
0
|
0
|
(49)
|
0
|
0
|
0
|
(61)
|
0
|
0
|
0
|
(59)
|
|
| Other Operating Expenses |
1
|
(7)
|
(7)
|
(7)
|
67
|
52
|
53
|
63
|
15
|
7
|
9
|
(4)
|
7
|
(0)
|
(2)
|
3
|
10
|
0
|
3
|
(1)
|
4
|
|
| Operating Income |
1 341
N/A
|
1 661
+24%
|
1 462
-12%
|
1 072
-27%
|
763
-29%
|
471
-38%
|
392
-17%
|
322
-18%
|
218
-32%
|
168
-23%
|
138
-18%
|
155
+12%
|
143
-8%
|
116
-19%
|
114
-2%
|
71
-37%
|
39
-46%
|
28
-27%
|
45
+60%
|
65
+44%
|
94
+43%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
(26)
|
(19)
|
(9)
|
22
|
79
|
107
|
145
|
184
|
124
|
132
|
135
|
100
|
145
|
134
|
108
|
101
|
103
|
83
|
85
|
83
|
86
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
|
| Total Other Income |
(2)
|
(4)
|
(4)
|
(4)
|
4
|
4
|
4
|
4
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
1 313
N/A
|
1 638
+25%
|
1 449
-12%
|
1 091
-25%
|
845
-22%
|
582
-31%
|
541
-7%
|
510
-6%
|
343
-33%
|
300
-12%
|
273
-9%
|
255
-7%
|
288
+13%
|
249
-13%
|
221
-11%
|
171
-22%
|
141
-18%
|
111
-21%
|
130
+17%
|
148
+14%
|
180
+21%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(185)
|
(243)
|
(213)
|
(157)
|
(125)
|
(80)
|
(71)
|
(70)
|
(39)
|
(28)
|
(27)
|
(22)
|
(28)
|
(29)
|
(26)
|
(17)
|
(19)
|
(10)
|
(11)
|
(15)
|
(32)
|
|
| Income from Continuing Operations |
1 128
|
1 396
|
1 236
|
933
|
720
|
502
|
470
|
440
|
303
|
273
|
247
|
232
|
260
|
220
|
195
|
154
|
122
|
101
|
119
|
133
|
148
|
|
| Net Income (Common) |
1 128
N/A
|
1 396
+24%
|
1 236
-11%
|
933
-24%
|
720
-23%
|
502
-30%
|
470
-6%
|
440
-6%
|
303
-31%
|
273
-10%
|
247
-10%
|
232
-6%
|
260
+12%
|
220
-15%
|
195
-11%
|
154
-21%
|
122
-21%
|
101
-17%
|
119
+18%
|
133
+12%
|
148
+11%
|
|
| EPS (Diluted) |
8.73
N/A
|
10.8
+24%
|
9.56
-11%
|
7.22
-24%
|
5.57
-23%
|
3.89
-30%
|
6.9
+77%
|
3.4
-51%
|
2.35
-31%
|
2.1
-11%
|
1.91
-9%
|
1.8
-6%
|
2.01
+12%
|
1.7
-15%
|
1.51
-11%
|
1.24
-18%
|
0.95
-23%
|
0.82
-14%
|
0.96
+17%
|
1.08
+13%
|
1.21
+12%
|
|
Switch to:
Switch to:
See Also
Discover More
